Presentation
Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis.
2018 Gastrointestinal Cancers Symposium
(2018)
Disciplines
Publication Date
January, 2018
Location
San Francisco, CA
Citation Information
Kenneth H. Yu, Simon Mantha, Catherine Tjan, Erica S. Kaufmann, et al.. "Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis." 2018 Gastrointestinal Cancers Symposium (2018) Available at: http://works.bepress.com/antonio-ucar/8/